Who is sponsoring NCT05753787?

NCT05753787 is sponsored by Spektrum Center of Clinical Ophthalmology.

What drugs are being tested in NCT05753787?

Interventions in NCT05753787: preservative-free solution of standard post-cataract eye drops.

What condition does NCT05753787 study?

NCT05753787 studies Cataract, Surgical Injury, Healing Wound.

Is NCT05753787 still recruiting?

NCT05753787 is currently status unknown. Last updated 28 September 2023.

Last reviewed 2023-09-28 · How we verify

NCT05753787: EyeSurface

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Eye Surface Properties After Using Dexamethasone Drops With and Without Preservatives in Patients After Cataract Surgery

Status unknown NA Last updated 28 September 2023

What this trial tests

NA trial testing preservative-free solution of standard post-cataract eye drops in Cataract in 40 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
31 December 2023

31 December 2025

Quick facts

Lead sponsor	Spektrum Center of Clinical Ophthalmology
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	health services research
Enrollment	40
Start date	1 January 2022
Primary completion	31 December 2023
Estimated completion	31 December 2025
Sites	1 location across Poland

Drugs / interventions tested

preservative-free solution of standard post-cataract eye drops

Conditions studied

Cataract — all drugs for Cataract →
Surgical Injury — all drugs for Surgical Injury →
Healing Wound — all drugs for Healing Wound →

Sponsor

Spektrum Center of Clinical Ophthalmology

Who can join

18 and older, any sex, with Cataract or Surgical Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this interventional, real world data study is to evaluate the impact of preservatives on the post-cataract ocular surface. The main question is to learn about an effect of preservatives on the eye surface. The study aims to answer some important questions: * if the usage of preservatives has an impact on the eye surface healing process after cataract surgery * if patient comfort and quality of life improve more or more rapidly with preservatives-free eye drops. Participants will be asked to undergo standard procedure of peri-cataract surgery care and in addition to survey about the ocular surface state. Researchers will compare group that takes preservatives-free dexamethasone 0.1% with standard dexamethasone 0.01% solution to see if post-surgery eye surface healing properties differ from both groups.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Assessment of the eye surface and subjective symptoms after using 0.1% dexamethasone drops with and without preservatives in patients after cataract surgery.
Muzyka-Woźniak M, Stróżecki Ł, Przeździecka-Dołyk J. · · 2023 · cited 6× · PMID 37903818 · DOI 10.1038/s41598-023-44939-1

Verify or expand the search:

Other recruiting trials for Cataract

Currently open trials in the same condition.

NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05753787 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Spektrum Center of Clinical Ophthalmology
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05753787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing